In conclusion, FAM83A is a potential immune-associated biomarker in LUAD biopsies and pleural effusion specimens, which provides a new and effective option for pleural effusion cytology and may become a key target in future therapeutic strategies. Here, SACK1A is linked to Pleural effusion.